Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study in EGFR Wild-Type Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology 2024
May 23, 2024
May 23, 2024
May 14, 2024
April 24, 2024
March 28, 2024
March 21, 2024
March 6, 2024
January 8, 2024
January 8, 2024
January 3, 2024
December 11, 2023